The company has an export quota of 50%
This company was born a decade ago from the research and development of solutions by its founder, Raúl Reyes, in response to the significant joint ailments of a family member.
This is how it came to Artrosy, its star and most recognized product, a cream composed of eight active ingredients necessary for the joints to maintain normal functioning.
Arthritis It can be found mainly in pharmacies and is classified as a Class 1 Medical Device by the Spanish Agency for Medicines and Health Products. To date, more than 300.000 units of this product have been sold, distributed through clients such as Bidafarma, Hefame or Actibios, among others.
From Aga Pharma, point out the activation of exports as the greatest milestone in their years of experience. The company has an export quota of 50%, sales that are mainly destined for Algeria, although they are currently finalizing contracts for entry into European countries such as Holland and the United Kingdom. Furthermore, its medium-term objective is to open the market in U.S.
In this international trajectory, Aga Pharma has had the support of Extenda-Andalusian Foreign Promotion Agency through different services and programs. “Polls in distant countries or individual agendas in Algeria, Portugal, United Kingdom and in other parts of Europe they have been key so that we can now export,” he comments. Raul Reyes, manager and founder of Aga Pharma.
The future plans of this Andalusian biotechnological laboratory involve continuing to innovate and develop new health products that improve the quality of life of citizens, while increasing sales in international markets. Europe and North America.





